State Street
TMCI icon

State Street’s Treace Medical Concepts TMCI Stock Holding History

State Street’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$932K Sell
234,271
-1,001,247
-81% -$2.75M ﹤0.01% 3475
2026
Q1 		$1.66M Buy
1,235,518
+241,327
+24% +$481K ﹤0.01% 3351
2025
Q4 		$2.44M Buy
994,191
+2,350
+0.2% +$10.2K ﹤0.01% 3279
2025
Q3 		$6.66M Buy
991,841
+5,855
+0.6% +$38.2K ﹤0.01% 2865
2025
Q2 		$5.8M Buy
985,986
+3,203
+0.3% +$20.9K ﹤0.01% 2875
2025
Q1 		$8.25M Buy
982,783
+16,351
+2% +$147K ﹤0.01% 2652
2024
Q4 		$7.19M Sell
966,432
-31,021
-3% -$208K ﹤0.01% 2799
2024
Q3 		$5.79M Buy
997,453
+39,907
+4% +$256K ﹤0.01% 2898
2024
Q2 		$6.37M Sell
957,546
-293,062
-23% -$2.37M ﹤0.01% 2813
2024
Q1 		$16.3M Sell
1,250,608
-164,656
-12% -$2.2M ﹤0.01% 2295
2023
Q4 		$18M Buy
1,415,264
+110,332
+8% +$1.11M ﹤0.01% 2266
2023
Q3 		$17.1M Buy
1,304,932
+146,940
+13% +$2.69M ﹤0.01% 2257
2023
Q2 		$29.6M Buy
1,157,992
+283,288
+32% +$7.31M ﹤0.01% 1987
2023
Q1 		$22M Buy
874,704
+87,530
+11% +$2.06M ﹤0.01% 2161
2022
Q4 		$18.1M Buy
787,174
+129,279
+20% +$2.98M ﹤0.01% 2314
2022
Q3 		$14.5M Buy
657,895
+174,080
+36% +$3.37M ﹤0.01% 2468
2022
Q2 		$6.94M Sell
483,815
-2,961
-0.6% -$49.9K ﹤0.01% 2931
2022
Q1 		$9.21M Buy
486,776
+84,142
+21% +$1.64M ﹤0.01% 2870
2021
Q4 		$7.5M Buy
402,634
+224,107
+126% +$4.63M ﹤0.01% 3057
2021
Q3 		$4.8M Buy
178,527
+24,364
+16% +$670K ﹤0.01% 3259
2021
Q2 		$4.82M Buy
+154,163
New +$4.91M ﹤0.01% 3263

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street's TMCI Position: Q2 2026 in Review

State Street reduced its Treace Medical Concepts (TMCI) stake by 81% in Q2 2026, selling an estimated $2.75M and leaving 234,271 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #3475.

State Street first reported a position in TMCI in Q2 2021 and has held it in 21 quarters since. The position peaked at $29.6M in Q2 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • State Street held 234,271 shares of Treace Medical Concepts worth $932K as of Q2 2026.
  • State Street sold 1,001,247 Treace Medical Concepts shares in Q2 2026, an estimated $2.75M.
  • Treace Medical Concepts made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3475 holding.
  • State Street first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 21 quarters since.
  • State Street's Treace Medical Concepts position peaked at $29.6M in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.